| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_829c4ab17debe4a885a34e8e9fa66b0f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-0046 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00 |
| filingDate |
2018-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_690edd86150ac81d6d4974260fe343a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_369daf5f6fb5374ac5750c088df3ff48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6d41f071529a51a9911f91cdfde175a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95a17ffb55acca7614d464f95ef0fe00 |
| publicationDate |
2018-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-108250249-A |
| titleOfInvention |
A kind of quinoline ruthenium complex or its crystal and preparation method |
| abstract |
The present invention relates to a kind of quinoline ruthenium complex shown in following formula (5) or its crystal and preparation method, R 1 and R 2 are each independently selected from H or C 1-6 alkyl. After research, it is found that the complex or its crystal has good physiological activity and can significantly intercalate with DNA, thus providing a good application basis and potential for continued research for subsequent drug development. |
| priorityDate |
2018-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |